Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6158458 | American Journal of Kidney Diseases | 2010 | 4 Pages |
Abstract
Lupus nephritis is a major manifestation of systemic lupus erythematosus. Treatment with such immunosuppressive agents as corticosteroids or cyclophosphamide can decrease the progression of lupus nephritis; however, these agents have potentially severe adverse reactions. Therefore, the development of new drugs with fewer side effects is needed. Here, we report 2 patients with lupus that were treated successfully with retinoids. Initially, both patients were treated with 60 mg/d of prednisolone. However, nephrotic syndrome was not improved. Subsequently, treatment with 10 mg/d of all-trans-retinoic acid was started orally and elicited a good response, showing a decrease in proteinuria. Although additional controlled clinical studies are needed to confirm these findings, we suggest that therapy using retinoids may represent a novel approach to the treatment of patients with lupus nephritis.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Koji MD, PhD, Kazuya MD, Hideki MD, Yuji MD, PhD, Masafumi MD, PhD, Shinya MD, PhD, Masanori MD, PhD,